<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Creatine and ATP Resynthesis: The 10-Second Energy Window</title>
  <meta name="description" content="Quantitative analysis of creatine&#39;s role in ATP resynthesis: turnover rates, phosphocreatine contribution during maximal effort, the 10-second window,...">
  <meta name="robots" content="index, follow">
  <link rel="canonical" href="https://creatineresearch.co/science/creatine-atp-resynthesis">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://creatineresearch.co/science/creatine-atp-resynthesis">
  <meta property="og:title" content="Creatine and ATP Resynthesis: The 10-Second Energy Window">
  <meta property="og:description" content="Quantitative analysis of creatine&#39;s role in ATP resynthesis: turnover rates, phosphocreatine contribution during maximal effort, the 10-second window,...">
  <meta property="og:site_name" content="Creatine Research">
  <meta name="twitter:card" content="summary_large_image">
  <meta name="twitter:title" content="Creatine and ATP Resynthesis: The 10-Second Energy Window">
  <meta name="twitter:description" content="Quantitative analysis of creatine&#39;s role in ATP resynthesis: turnover rates, phosphocreatine contribution during maximal effort, the 10-second window,...">
  <script type="application/ld+json">
  [
    {
      "@context": "https://schema.org",
      "@type": "TechArticle",
      "headline": "Creatine and ATP Resynthesis: The 10-Second Energy Window",
      "description": "Quantitative analysis of creatine's role in ATP resynthesis: turnover rates, phosphocreatine contribution during maximal effort, the 10-second window, and recovery between bouts.",
      "url": "https://creatineresearch.co/science/creatine-atp-resynthesis",
      "datePublished": "2026-01-28",
      "dateModified": "2026-01-28",
      "publisher": {
        "@type": "Organization",
        "name": "Creatine Research",
        "url": "https://creatineresearch.co"
      },
      "author": {
        "@type": "Organization",
        "name": "Creatine Research"
      },
      "keywords": ["creatine atp", "ATP resynthesis", "ATP turnover", "phosphocreatine energy", "maximal effort duration"],
      "proficiencyLevel": "Expert"
    },
    {
      "@context": "https://schema.org",
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://creatineresearch.co/"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Science & Mechanisms",
          "item": "https://creatineresearch.co/science"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Creatine and ATP Resynthesis: The 10-Second Energy Window",
          "item": "https://creatineresearch.co/science/creatine-atp-resynthesis"
        }
      ]
    }
  ]
  </script>
  <script type="application/ld+json">
  {
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What is the atp turnover?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Resting skeletal muscle contains approximately 5.5 mmol of ATP per kilogram of wet tissue, or roughly 24 mmol/kg dry muscle (Casey et al., 1996). The total ATP content of the entire body at any instant is estimated at approximately 50-100 grams. That quantity contains enough energy for approximately 2-3 seconds of maximal muscular effort, a fact that makes the scale of ATP turnover remarkable."
      }
    },
    {
      "@type": "Question",
      "name": "What is the 10-second window?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The phrase \"10-second energy window\" describes the period during maximal effort when the phosphocreatine system is the dominant mechanism of ATP resynthesis. This window is not a hard boundary but a practical approximation that emerges from the kinetics of PCr depletion and the relative contribution of competing energy systems."
      }
    },
    {
      "@type": "Question",
      "name": "What is the pcr contribution to atp resynthesis during specific activities?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The 10-second window maps onto specific athletic activities with useful precision:"
      }
    },
    {
      "@type": "Question",
      "name": "What is the recovery between bouts?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Perhaps the most practically important aspect of phosphocreatine kinetics is not the depletion phase but the recovery phase. Most sports and training scenarios involve repeated efforts with incomplete rest, and the rate at which PCr is resynthesized between bouts determines the quality of subsequent efforts."
      }
    },
    {
      "@type": "Question",
      "name": "What is the atp is defended, not depleted?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "One of the most misunderstood aspects of exercise bioenergetics is the relationship between PCr depletion and ATP depletion. They are not the same thing. The body treats ATP concentration as a near-inviolable parameter, defending it through multiple mechanisms even at the cost of reduced contractile performance."
      }
    }
  ]
}
  </script>

  <link rel="icon" type="image/svg+xml" href="data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 100 100'><rect fill='%230f172a' width='100' height='100' rx='12'/><text x='50' y='68' font-family='monospace' font-size='40' fill='%230284c7' text-anchor='middle'>Cr</text></svg>">
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=DM+Sans:wght@400;500;600;700&family=Instrument+Serif:ital@0;1&display=swap" rel="stylesheet">
  <script src="https://cdn.tailwindcss.com"></script>
  <script>
    tailwind.config = {
      darkMode: 'class',
      theme: {
        extend: {
          fontFamily: {
            sans: ['DM Sans', 'system-ui', 'sans-serif'],
            serif: ['Instrument Serif', 'Georgia', 'serif'],
          },
          colors: {
            slate: { 925: '#0c0f14', 950: '#090b10' }
          }
        }
      }
    }
  </script>
  <style>
    ::selection { background: rgba(2, 132, 199, 0.3); }
    ::-webkit-scrollbar { width: 8px; }
    ::-webkit-scrollbar-track { background: var(--bg-secondary, #18181b); }
    ::-webkit-scrollbar-thumb { background: var(--border, #27272a); border-radius: 4px; }
    ::-webkit-scrollbar-thumb:hover { background: #3f3f46; }

    /* Article body — light mode */
    .article-body { max-width: 720px; margin: 0 auto; padding: 0 1rem; }
    .article-body h1 { font-family: 'Instrument Serif', Georgia, serif; font-size: 2.75rem; line-height: 1.15; margin-bottom: 1rem; color: #0f172a; }
    .article-body h2 { font-family: 'Instrument Serif', Georgia, serif; font-size: 1.875rem; margin: 2.5rem 0 1rem; color: #0f172a; }
    .article-body h3 { font-size: 1.25rem; font-weight: 600; margin: 2rem 0 0.75rem; color: #0f172a; }
    .article-body p { margin-bottom: 1.5rem; color: #475569; line-height: 1.8; }
    .article-body a { color: #0284c7; text-decoration: none; }
    .article-body a:hover { text-decoration: underline; }
    .article-body ul, .article-body ol { margin: 1.5rem 0; padding-left: 1.5rem; color: #475569; }
    .article-body li { margin-bottom: 0.75rem; line-height: 1.7; }
    .article-body strong { color: #1e293b; }
    .article-body blockquote { border-left: 3px solid #0284c7; padding-left: 1.5rem; margin: 2rem 0; font-style: italic; color: #334155; }
    .article-body .meta { color: #64748b; font-size: 0.9rem; margin-bottom: 2rem; }
    .article-body table { width: 100%; border-collapse: collapse; margin: 2rem 0; }
    .article-body th, .article-body td { text-align: left; padding: 0.75rem 1rem; border-bottom: 1px solid #e2e8f0; color: #475569; }
    .article-body th { color: #0f172a; font-weight: 600; border-bottom: 2px solid #cbd5e1; }
    .article-body .cta-box {
      background: linear-gradient(135deg, rgba(2, 132, 199, 0.08), rgba(13, 148, 136, 0.04));
      border: 1px solid rgba(2, 132, 199, 0.2);
      border-radius: 16px; padding: 2.5rem; margin: 3rem 0; text-align: center;
    }
    .article-body .cta-box h3 { margin-top: 0; font-family: 'Instrument Serif', Georgia, serif; font-size: 1.5rem; }
    .article-body .cta-box p { color: #64748b; margin-bottom: 1.5rem; }
    .article-body .cta-button {
      display: inline-block; background: #0284c7; color: #ffffff;
      padding: 1rem 2rem; border-radius: 8px; font-weight: 600;
      text-decoration: none; transition: background 0.2s;
    }
    .article-body .cta-button:hover { background: #0ea5e9; text-decoration: none; }
    .article-body .related-articles { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid #e2e8f0; }
    .article-body .related-articles h3 { margin-bottom: 1rem; }
    .article-body .related-articles ul { list-style: none; padding: 0; }
    .article-body .related-articles li { margin-bottom: 0.5rem; }
    .article-body .faq-section { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid #e2e8f0; }
    .article-body .faq-section > h2 { margin-top: 0; }
    .article-body .faq-item { margin-bottom: 2rem; }
    .article-body .faq-item h3 { color: #0f172a; margin-bottom: 0.5rem; }
    .article-body .faq-item p { margin-bottom: 0; }

    /* Article body — dark mode */
    .dark .article-body h1, .dark .article-body h2, .dark .article-body h3 { color: #fafaf9; }
    .dark .article-body p { color: #a1a1aa; }
    .dark .article-body ul, .dark .article-body ol { color: #a1a1aa; }
    .dark .article-body strong { color: #e4e4e7; }
    .dark .article-body a { color: #38bdf8; }
    .dark .article-body blockquote { color: #d4d4d8; }
    .dark .article-body .meta { color: #71717a; }
    .dark .article-body th, .dark .article-body td { border-bottom-color: #27272a; color: #a1a1aa; }
    .dark .article-body th { color: #fafaf9; border-bottom-color: #3f3f46; }
    .dark .article-body .cta-box { background: linear-gradient(135deg, rgba(2, 132, 199, 0.12), rgba(13, 148, 136, 0.06)); }
    .dark .article-body .cta-box p { color: #a1a1aa; }
    .dark .article-body .related-articles { border-top-color: #27272a; }
    .dark .article-body .faq-section { border-top-color: #27272a; }
    .dark .article-body .faq-item h3 { color: #fafaf9; }

    /* Newsletter section */
    #newsletter input::placeholder { color: #94a3b8; }
    .dark #newsletter input::placeholder { color: #52525b; }


    /* Mega menu */
    .mega-panel { transition: opacity 0.15s ease, visibility 0.15s ease; }
    .mega-panel.hidden { opacity: 0; visibility: hidden; display: none; }
    .mega-panel:not(.hidden) { opacity: 1; visibility: visible; display: block; }
    .mega-link {
      display: block; padding: 6px 0;
      font-size: 0.875rem; color: #475569;
      transition: color 0.15s;
    }
    .mega-link:hover { color: #0f172a; text-decoration: none; }
    .dark .mega-link { color: #a1a1aa; }
    .dark .mega-link:hover { color: #fafaf9; }
    .mega-view-all {
      display: inline-block; margin-top: 12px;
      font-size: 0.8125rem; font-weight: 500;
      color: #0284c7; transition: color 0.15s;
    }
    .mega-view-all:hover { color: #0ea5e9; text-decoration: none; }
    .dark .mega-view-all { color: #38bdf8; }
    .dark .mega-view-all:hover { color: #7dd3fc; }

    /* Nav effects */
    .nav-link { position: relative; }
    .nav-link::after {
      content: ''; position: absolute; bottom: -2px; left: 0;
      width: 0; height: 1px; background: #0284c7; transition: width 0.3s ease;
    }
    .nav-link:hover::after { width: 100%; }
    .cta-glow { position: relative; }
    .cta-glow::before {
      content: ''; position: absolute; inset: -2px;
      background: linear-gradient(135deg, #0284c7, #0891b2);
      border-radius: inherit; opacity: 0; filter: blur(12px);
      transition: opacity 0.3s ease; z-index: -1;
    }
    .cta-glow:hover::before { opacity: 0.4; }

    /* Active trigger state */
    .mega-trigger[aria-expanded="true"] { color: #0f172a; }
    .dark .mega-trigger[aria-expanded="true"] { color: #fafaf9; }
    .mega-trigger[aria-expanded="true"] svg { transform: rotate(180deg); }


    @media (max-width: 768px) {
      .article-body h1 { font-size: 2rem; }
      .article-body h2 { font-size: 1.5rem; }
    }
  </style>
</head>
<body class="bg-slate-50 dark:bg-slate-950 font-sans antialiased">

  <nav class="fixed top-0 left-0 right-0 z-50 border-b border-slate-200 dark:border-zinc-800/60 bg-white/90 dark:bg-slate-950/90 backdrop-blur-md">
    <div class="max-w-7xl mx-auto">
      <div class="flex items-center justify-between h-16 px-6">
        <!-- Logo -->
        <a href="/" class="flex items-center gap-3 group">
          <div class="w-8 h-8 rounded-md bg-slate-100 dark:bg-zinc-800 border border-slate-200 dark:border-zinc-700 flex items-center justify-center group-hover:border-sky-500/50 transition-colors">
            <svg class="w-4 h-4 text-sky-600 dark:text-sky-400" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
          </div>
          <span class="text-slate-500 dark:text-zinc-400 text-sm tracking-tight">
            <span class="text-slate-800 dark:text-zinc-200 font-medium">Creatine</span><span class="text-sky-600 dark:text-sky-400">Research</span>
          </span>
        </a>

        <!-- Desktop Nav -->
        <div class="hidden lg:flex items-center gap-1">

          <!-- Science dropdown -->
          <div class="relative" data-mega="science">
            <button class="mega-trigger nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors flex items-center gap-1">
              Research
              <svg class="w-3 h-3 opacity-50 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
            </button>
          </div>

          <!-- Applications dropdown -->
          <div class="relative" data-mega="applications">
            <button class="mega-trigger nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors flex items-center gap-1">
              Applications
              <svg class="w-3 h-3 opacity-50 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
            </button>
          </div>

          <!-- All Articles link -->
          <a href="/articles" class="nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors">All Articles</a>

          <div class="w-px h-4 bg-slate-300 dark:bg-zinc-800 mx-2"></div>

          <!-- CTA -->
          <a href="#newsletter" class="px-5 py-2 text-sm font-semibold bg-sky-600 hover:bg-sky-500 text-white rounded-md transition-colors cta-glow">Research Updates</a>
        </div>

        <!-- Mobile menu button -->
        <button id="mobile-menu-btn" class="lg:hidden p-2 text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200">
          <svg id="menu-icon" class="w-5 h-5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
          <svg id="close-icon" class="w-5 h-5 hidden" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M6 18L18 6M6 6l12 12"></path></svg>
        </button>
      </div>

      <!-- ═══ MEGA PANEL: Research ═══ -->
      <div id="mega-science" class="mega-panel hidden border-t border-slate-200 dark:border-zinc-800/60 bg-white dark:bg-slate-950">
        <div class="max-w-7xl mx-auto px-6 py-8">
          <div class="grid grid-cols-3 gap-8">
            <!-- Column 1: Science -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-sky-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Science & Mechanisms</span>
              </div>
              <div class="space-y-1">
                <a href="/science/what-is-creatine-monohydrate" class="mega-link">What Is Creatine Monohydrate?</a>
                <a href="/science/how-creatine-works-in-the-body" class="mega-link">How Creatine Works</a>
                <a href="/science/creatine-atp-resynthesis" class="mega-link">ATP Resynthesis</a>
                <a href="/science/creatine-and-muscle-growth" class="mega-link">Muscle Growth Research</a>
                <a href="/science/creatine-and-brain-function" class="mega-link">Brain Function</a>
                <a href="/science/creatine-and-aging" class="mega-link">Aging & Sarcopenia</a>
              </div>
              <a href="/science" class="mega-view-all">All 20 articles &rarr;</a>
            </div>

            <!-- Column 2: Dosing & Safety -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-teal-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12h6m-6 4h6m2 5H7a2 2 0 01-2-2V5a2 2 0 012-2h5.586a1 1 0 01.707.293l5.414 5.414a1 1 0 01.293.707V19a2 2 0 01-2 2z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Dosing & Safety</span>
              </div>
              <div class="space-y-1">
                <a href="/dosing/creatine-loading-protocol" class="mega-link">Loading Protocol</a>
                <a href="/dosing/creatine-maintenance-dose" class="mega-link">Maintenance Dosing</a>
                <a href="/dosing/creatine-timing-before-or-after-workout" class="mega-link">Timing: Before or After?</a>
                <a href="/safety/is-creatine-safe" class="mega-link">Is Creatine Safe?</a>
                <a href="/safety/creatine-and-kidneys" class="mega-link">Kidney Health</a>
                <a href="/safety/creatine-and-hair-loss" class="mega-link">Hair Loss Myth</a>
              </div>
              <a href="/dosing" class="mega-view-all">Dosing (15) &rarr;</a>
              <span class="mx-2 text-slate-300 dark:text-zinc-700">|</span>
              <a href="/safety" class="mega-view-all">Safety (15) &rarr;</a>
            </div>

            <!-- Column 3: CTA Card -->
            <div class="bg-gradient-to-br from-sky-500/10 to-teal-500/5 dark:from-sky-500/15 dark:to-teal-500/5 border border-sky-500/20 rounded-xl p-6 flex flex-col justify-between">
              <div>
                <h3 class="text-lg font-semibold text-slate-900 dark:text-zinc-100 mb-2">Evidence-Based Research</h3>
                <p class="text-sm text-slate-600 dark:text-zinc-400 mb-4">Every article cites peer-reviewed studies. No marketing hype. Just what the science shows.</p>
              </div>
              <a href="/science/creatine-mechanisms-summary" class="inline-flex items-center justify-center px-6 py-3 bg-sky-600 hover:bg-sky-500 text-white font-semibold rounded-lg text-sm transition-colors cta-glow">
                Complete Research Guide
              </a>
            </div>
          </div>
        </div>
      </div>

      <!-- ═══ MEGA PANEL: Applications ═══ -->
      <div id="mega-applications" class="mega-panel hidden border-t border-slate-200 dark:border-zinc-800/60 bg-white dark:bg-slate-950">
        <div class="max-w-7xl mx-auto px-6 py-8">
          <div class="grid grid-cols-4 gap-8">
            <!-- Column 1: By Sport -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-amber-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 10V3L4 14h7v7l9-11h-7z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">By Sport</span>
              </div>
              <div class="space-y-1">
                <a href="/sports/creatine-for-powerlifting" class="mega-link">Powerlifting</a>
                <a href="/sports/creatine-for-bodybuilding" class="mega-link">Bodybuilding</a>
                <a href="/sports/creatine-for-crossfit" class="mega-link">CrossFit</a>
                <a href="/sports/creatine-for-mma" class="mega-link">MMA & Combat Sports</a>
                <a href="/sports/creatine-for-soccer" class="mega-link">Soccer</a>
                <a href="/sports/creatine-for-swimming" class="mega-link">Swimming</a>
              </div>
              <a href="/sports" class="mega-view-all">All 20 sports &rarr;</a>
            </div>

            <!-- Column 2: Comparisons -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-violet-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M8 7h12m0 0l-4-4m4 4l-4 4m0 6H4m0 0l4 4m-4-4l4-4"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">vs Other Supplements</span>
              </div>
              <div class="space-y-1">
                <a href="/comparisons/creatine-vs-protein-powder" class="mega-link">vs Protein Powder</a>
                <a href="/comparisons/creatine-vs-bcaa" class="mega-link">vs BCAAs</a>
                <a href="/comparisons/creatine-vs-beta-alanine" class="mega-link">vs Beta-Alanine</a>
                <a href="/comparisons/creatine-vs-pre-workout" class="mega-link">vs Pre-Workout</a>
                <a href="/comparisons/creatine-vs-ashwagandha" class="mega-link">vs Ashwagandha</a>
              </div>
              <a href="/comparisons" class="mega-view-all">All 15 comparisons &rarr;</a>
            </div>

            <!-- Column 3: Product Quality -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-emerald-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m5.618-4.016A11.955 11.955 0 0112 2.944a11.955 11.955 0 01-8.618 3.04A12.02 12.02 0 003 9c0 5.591 3.824 10.29 9 11.622 5.176-1.332 9-6.03 9-11.622 0-1.042-.133-2.052-.382-3.016z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Product Quality</span>
              </div>
              <div class="space-y-1">
                <a href="/quality/creatine-monohydrate-vs-hcl" class="mega-link">Monohydrate vs HCl</a>
                <a href="/quality/creatine-forms-comparison" class="mega-link">All Forms Compared</a>
                <a href="/quality/third-party-testing-creatine" class="mega-link">Third-Party Testing</a>
                <a href="/quality/creapure-vs-generic-creatine" class="mega-link">Creapure vs Generic</a>
                <a href="/quality/creatine-buying-guide" class="mega-link">Buying Guide</a>
              </div>
              <a href="/quality" class="mega-view-all">All 15 guides &rarr;</a>
            </div>

            <!-- Column 4: Quick Links -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-sky-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 7h8m0 0v8m0-8l-8 8-4-4-6 6"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Quick Links</span>
              </div>
              <div class="space-y-1">
                <a href="/science/creatine-mechanisms-summary" class="mega-link">Complete Science Guide</a>
                <a href="/dosing/creatine-dosing-protocols-summary" class="mega-link">Complete Dosing Guide</a>
                <a href="/safety/creatine-safety-complete-guide" class="mega-link">Complete Safety Guide</a>
                <a href="/sports/creatine-for-sport-summary" class="mega-link">Every Sport Guide</a>
                <a href="/quality/creatine-buying-guide" class="mega-link">Buying Guide</a>
              </div>
              <a href="/articles" class="mega-view-all">All 100 articles &rarr;</a>
            </div>
          </div>
        </div>
      </div>

      <!-- ═══ Mobile Menu ═══ -->
      <div id="mobile-menu" class="hidden lg:hidden border-t border-slate-200 dark:border-zinc-800 bg-white dark:bg-slate-950 max-h-[80vh] overflow-y-auto">
        <div class="px-6 py-4 space-y-1">
          <!-- Research -->
          <button class="mobile-section-toggle w-full flex items-center justify-between py-3 text-slate-800 dark:text-zinc-200 font-medium">
            Research
            <svg class="w-4 h-4 text-slate-400 dark:text-zinc-600 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
          </button>
          <div class="mobile-section hidden pl-4 pb-3 space-y-1">
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-1 pb-1">Science</p>
            <a href="/science/what-is-creatine-monohydrate" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">What Is Creatine?</a>
            <a href="/science/how-creatine-works-in-the-body" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">How Creatine Works</a>
            <a href="/science" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 20 articles &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Dosing</p>
            <a href="/dosing/creatine-loading-protocol" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Loading Protocol</a>
            <a href="/dosing/creatine-maintenance-dose" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Maintenance Dose</a>
            <a href="/dosing" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 articles &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Safety</p>
            <a href="/safety/is-creatine-safe" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Is Creatine Safe?</a>
            <a href="/safety/creatine-and-kidneys" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Kidney Health</a>
            <a href="/safety" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 articles &rarr;</a>
          </div>

          <!-- Applications -->
          <button class="mobile-section-toggle w-full flex items-center justify-between py-3 text-slate-800 dark:text-zinc-200 font-medium">
            Applications
            <svg class="w-4 h-4 text-slate-400 dark:text-zinc-600 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
          </button>
          <div class="mobile-section hidden pl-4 pb-3 space-y-1">
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-1 pb-1">Sports</p>
            <a href="/sports/creatine-for-powerlifting" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Powerlifting</a>
            <a href="/sports/creatine-for-bodybuilding" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Bodybuilding</a>
            <a href="/sports" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 20 sports &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Comparisons</p>
            <a href="/comparisons/creatine-vs-protein-powder" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">vs Protein Powder</a>
            <a href="/comparisons/creatine-vs-bcaa" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">vs BCAAs</a>
            <a href="/comparisons" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 comparisons &rarr;</a>
          </div>

          <!-- Direct links -->
          <a href="/articles" class="block py-3 text-slate-800 dark:text-zinc-200 font-medium">All Articles</a>

          <!-- CTA -->
          <a href="#newsletter" class="block mt-4 py-3 bg-sky-600 text-white text-center font-semibold rounded-lg">Get Research Updates</a>
        </div>
      </div>
    </div>
  </nav>

  <main class="pt-24 pb-16">
    <div class="max-w-3xl mx-auto px-4 sm:px-6 mb-6">
      <div class="flex items-center gap-2 text-sm">
        <a href="/" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Home</a>
        <span class="text-slate-300 dark:text-zinc-700">/</span>
        <a href="/articles" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Articles</a>
        <span class="text-slate-300 dark:text-zinc-700">/</span>
        <a href="/science" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Science & Mechanisms</a>
      </div>
    </div>
    <div class="article-body">
      <article>
  <h1>Creatine and ATP Resynthesis: The 10-Second Energy Window</h1>

  <p>There is a paradox at the heart of exercise bioenergetics. Muscle ATP concentration barely changes during exercise, even during maximal effort, yet ATP is being consumed at extraordinary rates. During a 100-meter sprint, a human body turns over its entire ATP pool approximately 40-70 times. The concentration stays roughly constant not because usage is low but because regeneration is astonishingly fast. Phosphocreatine is the molecule responsible for the fastest phase of that regeneration, and the rate at which it operates defines a performance window of approximately 10 seconds that is the central fact of anaerobic power.</p>

  <section>
    <h2>ATP Turnover: The Numbers</h2>

    <p>Resting skeletal muscle contains approximately 5.5 mmol of ATP per kilogram of wet tissue, or roughly 24 mmol/kg dry muscle (Casey et al., 1996). The total ATP content of the entire body at any instant is estimated at approximately 50-100 grams. That quantity contains enough energy for approximately 2-3 seconds of maximal muscular effort, a fact that makes the scale of ATP turnover remarkable.</p>

    <p>During maximal-intensity exercise, ATP turnover in active muscle reaches approximately 15 mmol/kg wet weight per second. For the whole body during a 100-meter sprint, total ATP turnover has been estimated at roughly 35-40 mmol/kg dry muscle over the 10-second race duration (Hirvonen et al., 1987). Given that the resting ATP pool is only about 24 mmol/kg dry muscle, this means the body regenerates its entire ATP supply roughly 1.5 times during a single sprint. Over the course of a day at moderate activity, the body synthesizes and breaks down approximately 40-70 kg of ATP, roughly equivalent to its own body weight.</p>

    <p>Despite this enormous throughput, intramuscular ATP concentrations decline by only about 20-40% during the most demanding exercise. Even at the point of exhaustion during a 30-second Wingate test, Casey et al. (1996) measured ATP concentrations of approximately 17 mmol/kg dry muscle, down from a resting value of about 24 mmol/kg. The body defends ATP levels aggressively, and the phosphocreatine system is the first line of that defense.</p>
  </section>

  <section>
    <h2>The 10-Second Window</h2>

    <p>The phrase "10-second energy window" describes the period during maximal effort when the phosphocreatine system is the dominant mechanism of ATP resynthesis. This window is not a hard boundary but a practical approximation that emerges from the kinetics of PCr depletion and the relative contribution of competing energy systems.</p>

    <p>Harris et al. (1992), Hultman et al. (1996), and Casey et al. (1996) collectively established the empirical basis for this window:</p>

    <ul>
      <li>Resting PCr levels average approximately 75-85 mmol/kg dry muscle in the quadriceps.</li>
      <li>During the first 1.3 seconds of maximal effort, ATP is consumed primarily from stored ATP. PCr hydrolysis begins essentially simultaneously but reaches its peak rate within the first 2-3 seconds.</li>
      <li>By 6 seconds, approximately 50% of PCr has been consumed.</li>
      <li>By 10 seconds, approximately 60-70% is gone.</li>
      <li>Between 10 and 30 seconds, the remaining PCr depletes slowly while glycolysis assumes the majority of ATP regeneration.</li>
    </ul>

    <p>The rate of ATP resynthesis from PCr follows first-order kinetics tied to the concentrations of both phosphocreatine and ADP, per the creatine kinase equilibrium. As PCr drops, the reaction rate decreases. At 10 seconds into maximal effort, the PCr contribution to total ATP resynthesis has fallen below that of glycolysis. That crossover point, not an on-off switch, defines the end of the window.</p>

    <h3>Quantifying the Contribution</h3>

    <p>Spriet et al. (1989) and Bogdanis et al. (1996) quantified the relative contribution of energy systems during 6-second and 30-second maximal cycling bouts. During a 6-second sprint, approximately 50% of total ATP resynthesis was attributed to PCr hydrolysis, 44% to anaerobic glycolysis, and 6% to aerobic metabolism. During a 30-second effort, the contribution shifted to approximately 25% from PCr, 49% from glycolysis, and 26% from aerobic sources.</p>

    <p>These numbers carry practical weight. They mean that during the explosive efforts that define sprinting, jumping, throwing, and the first seconds of a heavy lift, phosphocreatine supplies half the ATP. Any supplement or training strategy that increases PCr availability directly affects performance during these efforts.</p>
  </section>

  <section>
    <h2>PCr Contribution to ATP Resynthesis During Specific Activities</h2>

    <p>The 10-second window maps onto specific athletic activities with useful precision:</p>

    <table>
      <thead>
        <tr>
          <th>Activity</th>
          <th>Duration</th>
          <th>Estimated PCr Contribution</th>
        </tr>
      </thead>
      <tbody>
        <tr><td>Single maximal jump or throw</td><td>&lt;1 second</td><td>~70-80% (primarily stored ATP + PCr)</td></tr>
        <tr><td>Olympic weightlifting attempt</td><td>1-3 seconds</td><td>~60-70%</td></tr>
        <tr><td>40-yard dash / 40m sprint</td><td>4-5 seconds</td><td>~50-55%</td></tr>
        <tr><td>100m sprint</td><td>10-12 seconds</td><td>~40-50%</td></tr>
        <tr><td>200m sprint</td><td>20-24 seconds</td><td>~25-30%</td></tr>
        <tr><td>400m run</td><td>45-55 seconds</td><td>~10-15%</td></tr>
      </tbody>
    </table>

    <p>The relationship is clear: the shorter and more explosive the activity, the greater the relative importance of the phosphocreatine system. This explains the consistent finding in meta-analyses that creatine supplementation produces the largest effect sizes in efforts lasting under 30 seconds (Branch, 2003).</p>
  </section>

  <section>
    <h2>Recovery Between Bouts: Where Creatine Supplementation Shines</h2>

    <p>Perhaps the most practically important aspect of phosphocreatine kinetics is not the depletion phase but the recovery phase. Most sports and training scenarios involve repeated efforts with incomplete rest, and the rate at which PCr is resynthesized between bouts determines the quality of subsequent efforts.</p>

    <h3>Recovery Kinetics</h3>

    <p>PCr resynthesis is an aerobic process. After exercise, mitochondrial CK phosphorylates free creatine using ATP from oxidative phosphorylation. Harris et al. (1976) characterized the recovery time course:</p>

    <ul>
      <li>50% of PCr is restored within approximately 30 seconds of recovery.</li>
      <li>75% is restored by about 60 seconds.</li>
      <li>Full restoration requires approximately 3-5 minutes, with the final 10-15% of recovery being the slowest phase.</li>
    </ul>

    <p>The half-time of recovery (approximately 20-30 seconds in healthy, aerobically fit individuals) is determined by mitochondrial capacity. Better aerobic fitness produces faster PCr recovery, which is one reason endurance training improves repeated sprint ability even though the sprints themselves are anaerobic.</p>

    <h3>The Creatine Supplementation Advantage in Repeated Efforts</h3>

    <p>Creatine supplementation affects recovery between bouts through a mechanism that follows directly from the mass-action kinetics of the creatine kinase reaction. After a maximal effort, supplemented individuals have higher free creatine concentrations in the muscle (because they started with more total creatine). This higher free creatine provides more substrate for mitochondrial CK, driving faster phosphorylation. The net effect is faster PCr resynthesis during recovery intervals.</p>

    <p>Yquel et al. (2002) confirmed this using <sup>31</sup>P-MRS, measuring PCr recovery kinetics in creatine-supplemented and placebo groups. Supplemented subjects showed a significantly shorter PCr recovery half-time after maximal plantar flexion exercise. This finding has been replicated across multiple exercise modalities.</p>

    <p>The practical consequences are measurable. Casey et al. (1996) showed that during a protocol of two 30-second Wingate tests separated by 4 minutes of recovery, creatine-supplemented subjects maintained higher power output in the second bout compared to placebo. The magnitude of the difference was approximately 4-6% in mean power, a large effect in the context of maximal exercise performance.</p>

    <p>Bogdanis et al. (1996) studied two 30-second maximal cycling bouts separated by only 4 minutes and found that PCr resynthesis accounted for approximately 80% of the variability in second-bout performance. More PCr recovered meant more power output. Creatine supplementation shifts this relationship favorably.</p>

    <h3>Implications for Training and Competition</h3>

    <p>Most training protocols involve repeated sets with rest intervals. Most sports involve repeated sprints, plays, or efforts with variable recovery. In these contexts, the ability to restore PCr between efforts has outsized practical importance.</p>

    <p>Consider a strength training session: 5 sets of 3 repetitions at 90% of one-repetition maximum, with 3 minutes of rest between sets. Each set lasts approximately 6-10 seconds. Without supplementation, PCr recovery to ~95% takes about 3-4 minutes. With supplementation, the higher creatine pool and faster resynthesis rate mean that PCr levels at the start of each subsequent set are closer to full, producing more consistent force output across all five sets.</p>

    <p>In team sports like soccer or basketball, players perform 100-250 high-intensity sprints per match, most lasting 2-6 seconds, with variable recovery periods of 15-120 seconds. The cumulative advantage of marginally faster PCr recovery across hundreds of efforts can be substantial. Ostojic (2004) found that creatine-supplemented soccer players showed improved repeated sprint performance by the end of 90-minute simulated match play, consistent with this mechanism.</p>
  </section>

  <section>
    <h2>ATP Is Defended, Not Depleted</h2>

    <p>One of the most misunderstood aspects of exercise bioenergetics is the relationship between PCr depletion and ATP depletion. They are not the same thing. The body treats ATP concentration as a near-inviolable parameter, defending it through multiple mechanisms even at the cost of reduced contractile performance.</p>

    <p>During a 30-second Wingate test, PCr falls by 80-90%, but ATP falls by only 20-40% (Casey et al., 1996). Complete ATP depletion would trigger rigor (permanent cross-bridge formation) and potentially irreversible cellular damage. The cell has safeguards against this: as ATP drops and ADP accumulates, the adenylate kinase reaction (2 ADP -> ATP + AMP) provides a secondary buffer. AMP activates AMP deaminase, which converts AMP to IMP (inosine monophosphate), effectively removing it from the adenine nucleotide pool. This prevents further ATP regeneration until IMP is slowly reconverted, a process that takes hours rather than minutes (Sahlin and Broberg, 1990).</p>

    <p>This defense mechanism has a consequence. When very high-intensity exercise depletes PCr and partially depletes the adenine nucleotide pool through AMP deamination, full recovery of the total energy system requires significantly longer than PCr resynthesis alone. The 3-5 minutes for PCr recovery reflects only the creatine kinase equilibrium. Full restoration of the adenine nucleotide pool, including reconversion of IMP to AMP, may require 30-60 minutes or longer (Stathis et al., 1994).</p>

    <p>Creatine supplementation indirectly protects the adenine nucleotide pool by extending the period during which PCr can buffer ATP levels, reducing the degree to which ATP falls and consequently reducing the amount of AMP deamination. Stathis et al. (1994) found that creatine loading reduced IMP accumulation during intense exercise, suggesting a protective effect on the total adenine nucleotide pool.</p>
  </section>

  <section>
    <h2>Summary of Key Numbers</h2>

    <table>
      <thead>
        <tr>
          <th>Parameter</th>
          <th>Value</th>
          <th>Source</th>
        </tr>
      </thead>
      <tbody>
        <tr><td>Resting muscle ATP</td><td>~24 mmol/kg dry muscle</td><td>Casey et al. 1996</td></tr>
        <tr><td>Resting muscle PCr</td><td>~75-85 mmol/kg dry muscle</td><td>Harris et al. 1992</td></tr>
        <tr><td>PCr after creatine loading</td><td>~90-105 mmol/kg dry muscle</td><td>Hultman et al. 1996</td></tr>
        <tr><td>ATP turnover during maximal effort</td><td>~15 mmol/kg wet/second</td><td>Hultman et al. 1967</td></tr>
        <tr><td>PCr depletion at 10 seconds maximal effort</td><td>~58-70% of resting</td><td>Casey et al. 1996</td></tr>
        <tr><td>PCr recovery half-time</td><td>~20-30 seconds</td><td>Harris et al. 1976</td></tr>
        <tr><td>Time to ~95% PCr recovery</td><td>~3-4 minutes</td><td>Harris et al. 1976</td></tr>
        <tr><td>ATP decline during 30s Wingate</td><td>~20-40%</td><td>Casey et al. 1996</td></tr>
      </tbody>
    </table>
  </section>

  <section>
    <h2>Bibliography</h2>
    <ol>
      <li>Casey, A., Constantin-Teodosiu, D., Howell, S., Hultman, E. and Greenhaff, P.L. (1996). Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans. <em>American Journal of Physiology - Endocrinology and Metabolism</em>, 271(1), E31-E37. doi:10.1152/ajpendo.1996.271.1.E31</li>
      <li>Harris, R.C., Soderlund, K. and Hultman, E. (1992). Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. <em>Clinical Science</em>, 83(3), 367-374. doi:10.1042/cs0830367</li>
      <li>Hultman, E., Soderlund, K., Timmons, J.A., Cederblad, G. and Greenhaff, P.L. (1996). Muscle creatine loading in men. <em>Journal of Applied Physiology</em>, 81(1), 232-237. doi:10.1152/jappl.1996.81.1.232</li>
      <li>Harris, R.C., Edwards, R.H.T., Hultman, E., Nordesjo, L.O., Nylind, B. and Sahlin, K. (1976). The time course of phosphorylcreatine resynthesis during recovery of the quadriceps muscle in man. <em>Pflugers Archiv</em>, 367(2), 137-142. doi:10.1007/BF00585149</li>
      <li>Hirvonen, J., Rehunen, S., Rusko, H. and Harkonen, M. (1987). Breakdown of high-energy phosphate compounds and lactate accumulation during short supramaximal exercise. <em>European Journal of Applied Physiology and Occupational Physiology</em>, 56(3), 253-259. doi:10.1007/BF00690889</li>
      <li>Bogdanis, G.C., Nevill, M.E., Boobis, L.H. and Lakomy, H.K. (1996). Contribution of phosphocreatine and aerobic metabolism to energy supply during repeated sprint exercise. <em>Journal of Applied Physiology</em>, 80(3), 876-884. doi:10.1152/jappl.1996.80.3.876</li>
      <li>Spriet, L.L., Soderlund, K., Bergstrom, M. and Hultman, E. (1989). Anaerobic energy release in skeletal muscle during electrical stimulation in men. <em>Journal of Applied Physiology</em>, 62(2), 611-615. doi:10.1152/jappl.1987.62.2.611</li>
      <li>Branch, J.D. (2003). Effect of creatine supplementation on body composition and performance: a meta-analysis. <em>International Journal of Sport Nutrition and Exercise Metabolism</em>, 13(2), 198-226. doi:10.1123/ijsnem.13.2.198</li>
      <li>Yquel, R.J., Arsac, L.M., Thiaudiere, E., Canioni, P. and Manier, G. (2002). Effect of creatine supplementation on phosphocreatine resynthesis, inorganic phosphate accumulation and pH during intermittent maximal exercise. <em>Journal of Sports Sciences</em>, 20(5), 427-437. doi:10.1080/026404102317366681</li>
      <li>Ostojic, S.M. (2004). Creatine supplementation in young soccer players. <em>International Journal of Sport Nutrition and Exercise Metabolism</em>, 14(1), 95-103. doi:10.1123/ijsnem.14.1.95</li>
      <li>Stathis, C.G., Febbraio, M.A., Carey, M.F. and Snow, R.J. (1994). Influence of sprint training on human skeletal muscle purine nucleotide metabolism. <em>Journal of Applied Physiology</em>, 76(4), 1802-1809. doi:10.1152/jappl.1994.76.4.1802</li>
      <li>Sahlin, K. and Broberg, S. (1990). Adenine nucleotide depletion in human muscle during exercise: causality and significance of AMP deamination. <em>International Journal of Sports Medicine</em>, 11(Suppl 2), S62-S67. doi:10.1055/s-2007-1024856</li>
      <li>Wallimann, T., Tokarska-Schlattner, M. and Schlattner, U. (2011). The creatine kinase system and pleiotropic effects of creatine. <em>Amino Acids</em>, 40(5), 1271-1296. doi:10.1007/s00726-011-0877-3</li>
    </ol>
  </section>
      
      <section class="faq-section">
        <h2>Frequently Asked Questions</h2>
        
        <div class="faq-item">
          <h3>What is the atp turnover?</h3>
          <p>Resting skeletal muscle contains approximately 5.5 mmol of ATP per kilogram of wet tissue, or roughly 24 mmol/kg dry muscle (Casey et al., 1996). The total ATP content of the entire body at any instant is estimated at approximately 50-100 grams. That quantity contains enough energy for approximately 2-3 seconds of maximal muscular effort, a fact that makes the scale of ATP turnover remarkable.</p>
        </div>
        <div class="faq-item">
          <h3>What is the 10-second window?</h3>
          <p>The phrase "10-second energy window" describes the period during maximal effort when the phosphocreatine system is the dominant mechanism of ATP resynthesis. This window is not a hard boundary but a practical approximation that emerges from the kinetics of PCr depletion and the relative contribution of competing energy systems.</p>
        </div>
        <div class="faq-item">
          <h3>What is the pcr contribution to atp resynthesis during specific activities?</h3>
          <p>The 10-second window maps onto specific athletic activities with useful precision:</p>
        </div>
        <div class="faq-item">
          <h3>What is the recovery between bouts?</h3>
          <p>Perhaps the most practically important aspect of phosphocreatine kinetics is not the depletion phase but the recovery phase. Most sports and training scenarios involve repeated efforts with incomplete rest, and the rate at which PCr is resynthesized between bouts determines the quality of subsequent efforts.</p>
        </div>
        <div class="faq-item">
          <h3>What is the atp is defended, not depleted?</h3>
          <p>One of the most misunderstood aspects of exercise bioenergetics is the relationship between PCr depletion and ATP depletion. They are not the same thing. The body treats ATP concentration as a near-inviolable parameter, defending it through multiple mechanisms even at the cost of reduced contractile performance.</p>
        </div>
      </section>
      
      </article>

      <!-- In-article CTA -->
      <div class="cta-box">
        <h3>Stay Current on Creatine Research</h3>
        <p>Get evidence-based updates when new studies are published. No hype, no marketing — just what the science shows.</p>
        <a href="#newsletter" class="cta-button">Get Research Updates</a>
      </div>

      <!-- Pillar page link -->
      <div class="related-articles">
        <h3>Read the Full Guide</h3>
        <p style="margin-bottom: 0.75rem;"><a href="/science/creatine-mechanisms-summary">Complete Science Guide: Science & Mechanisms</a> — comprehensive overview with all cited sources.</p>
      </div>
    </div>

    <!-- Category nav -->
    <div class="max-w-3xl mx-auto px-4 sm:px-6 mt-12">
      <div class="flex items-center justify-between p-5 bg-slate-100 dark:bg-zinc-900/50 border border-slate-200 dark:border-zinc-800/60 rounded-xl">
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-1">Category</p>
          <a href="/science" class="text-slate-800 dark:text-zinc-200 font-medium hover:text-sky-600 dark:hover:text-sky-400 transition-colors">Science & Mechanisms</a>
        </div>
        <a href="/science" class="text-sm text-sky-600 dark:text-sky-400 font-medium hover:underline">Browse all &rarr;</a>
      </div>
    </div>
  </main>

  <!-- Newsletter section -->
  <section id="newsletter" class="py-16 bg-slate-100 dark:bg-zinc-900/30 border-t border-slate-200 dark:border-zinc-800/60">
    <div class="max-w-xl mx-auto px-6 text-center">
      <h2 class="font-serif text-3xl text-slate-900 dark:text-zinc-100 mb-3">Research Updates</h2>
      <p class="text-slate-600 dark:text-zinc-400 mb-6">New studies, mechanism breakdowns, and dosing insights — delivered when they matter. No spam. Unsubscribe anytime.</p>
      <form class="flex flex-col sm:flex-row gap-3 justify-center" onsubmit="return false;">
        <input type="email" placeholder="your@email.com" class="px-4 py-3 rounded-lg border border-slate-300 dark:border-zinc-700 bg-white dark:bg-zinc-800 text-slate-900 dark:text-zinc-100 focus:outline-none focus:ring-2 focus:ring-sky-500 w-full sm:w-72">
        <button type="submit" class="px-6 py-3 bg-sky-600 hover:bg-sky-500 text-white font-semibold rounded-lg transition-colors cta-glow">Subscribe</button>
      </form>
      <p class="text-xs text-slate-500 dark:text-zinc-600 mt-3">100% evidence-based. Every claim cited.</p>
    </div>
  </section>


  <footer class="py-16 border-t border-slate-200 dark:border-zinc-900">
    <div class="max-w-7xl mx-auto px-6">
      <div class="grid grid-cols-2 md:grid-cols-6 gap-8 mb-12">
        <div class="col-span-2 md:col-span-2">
          <div class="flex items-center gap-3 mb-3">
            <div class="w-8 h-8 rounded bg-slate-100 dark:bg-zinc-800 border border-slate-200 dark:border-zinc-700 flex items-center justify-center">
              <svg class="w-4 h-4 text-sky-600 dark:text-sky-400" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
            </div>
            <span class="text-slate-700 dark:text-zinc-300 font-medium">Creatine Research</span>
          </div>
          <p class="text-sm text-slate-600 dark:text-zinc-500 mb-6 max-w-xs">Evidence-based creatine research. Every claim cited. No marketing hype.</p>
          <a href="#newsletter" class="inline-block px-5 py-2 text-sm font-semibold bg-sky-600 hover:bg-sky-500 text-white rounded-md transition-colors">Research Updates</a>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Research</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/science" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Science</a></li>
            <li><a href="/dosing" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Dosing</a></li>
            <li><a href="/safety" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Safety</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Applications</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/sports" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">By Sport</a></li>
            <li><a href="/comparisons" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Comparisons</a></li>
            <li><a href="/quality" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Product Quality</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Guides</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/science/creatine-mechanisms-summary" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Science Guide</a></li>
            <li><a href="/dosing/creatine-dosing-protocols-summary" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Dosing Guide</a></li>
            <li><a href="/safety/creatine-safety-complete-guide" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Safety Guide</a></li>
            <li><a href="/quality/creatine-buying-guide" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Buying Guide</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Site</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Home</a></li>
            <li><a href="/articles" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">All Articles</a></li>
            <li><a href="https://scalewithsearch.com" target="_blank" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Scale With Search</a></li>
          </ul>
        </div>
      </div>
      <div class="pt-8 border-t border-slate-200 dark:border-zinc-900 flex flex-col md:flex-row items-center justify-between gap-4">
        <p class="text-xs text-slate-500 dark:text-zinc-700">&copy; 2026 Creatine Research. All cited sources are property of their respective authors.</p>
        <p class="text-xs text-slate-500 dark:text-zinc-700">Powered by <a href="https://scalewithsearch.com" target="_blank" class="text-slate-600 dark:text-zinc-500 hover:text-sky-500">Scale With Search</a></p>
      </div>
    </div>
  </footer>


  <script>
    // Theme
    if (localStorage.theme === 'light') {
      document.documentElement.classList.remove('dark');
    } else if (localStorage.theme === 'dark' || !('theme' in localStorage)) {
      document.documentElement.classList.add('dark');
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
      document.documentElement.classList.add('dark');
    }

    // Mega menu
    (function() {
      const triggers = document.querySelectorAll('.mega-trigger');
      const panels = document.querySelectorAll('.mega-panel');
      let activePanel = null;
      let closeTimeout = null;

      function openPanel(id) {
        clearTimeout(closeTimeout);
        panels.forEach(p => { p.classList.add('hidden'); });
        triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        const panel = document.getElementById('mega-' + id);
        const trigger = document.querySelector('[data-mega="' + id + '"] .mega-trigger');
        if (panel) { panel.classList.remove('hidden'); activePanel = panel; }
        if (trigger) trigger.setAttribute('aria-expanded', 'true');
      }

      function scheduleClose() {
        closeTimeout = setTimeout(() => {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
          activePanel = null;
        }, 200);
      }

      function cancelClose() { clearTimeout(closeTimeout); }

      triggers.forEach(btn => {
        const wrapper = btn.closest('[data-mega]');
        const id = wrapper.getAttribute('data-mega');
        btn.addEventListener('mouseenter', () => openPanel(id));
        btn.addEventListener('click', (e) => {
          e.preventDefault();
          const panel = document.getElementById('mega-' + id);
          if (panel && !panel.classList.contains('hidden')) {
            panel.classList.add('hidden');
            btn.setAttribute('aria-expanded', 'false');
          } else {
            openPanel(id);
          }
        });
        wrapper.addEventListener('mouseleave', scheduleClose);
      });

      panels.forEach(panel => {
        panel.addEventListener('mouseenter', cancelClose);
        panel.addEventListener('mouseleave', scheduleClose);
      });

      document.addEventListener('click', (e) => {
        if (!e.target.closest('[data-mega]') && !e.target.closest('.mega-panel')) {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        }
      });

      document.addEventListener('keydown', (e) => {
        if (e.key === 'Escape') {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        }
      });
    })();

    // Mobile menu
    const mobileMenuBtn = document.getElementById('mobile-menu-btn');
    const mobileMenu = document.getElementById('mobile-menu');
    const menuIcon = document.getElementById('menu-icon');
    const closeIcon = document.getElementById('close-icon');
    if (mobileMenuBtn) {
      mobileMenuBtn.addEventListener('click', () => {
        mobileMenu.classList.toggle('hidden');
        menuIcon.classList.toggle('hidden');
        closeIcon.classList.toggle('hidden');
      });
    }

    // Mobile accordion sections
    document.querySelectorAll('.mobile-section-toggle').forEach(btn => {
      btn.addEventListener('click', () => {
        const section = btn.nextElementSibling;
        const chevron = btn.querySelector('svg');
        section.classList.toggle('hidden');
        chevron.style.transform = section.classList.contains('hidden') ? '' : 'rotate(180deg)';
      });
    });
  </script>
</body>
</html>